Cargando…

Metreleptin Robustly Increases Resting-state Brain Connectivity in Treatment-naïve Female Patients With Lipodystrophy

CONTEXT: Research in lipodystrophy (LD) and its treatment with metreleptin has not only helped patients with LD but has opened new directions in investigating leptin's role in metabolism and the regulation of eating behavior. Previously, in a study with patients with LD undergoing metreleptin t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schlögl, Haiko, Villringer, Arno, Miehle, Konstanze, Fasshauer, Mathias, Stumvoll, Michael, Mueller, Karsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315645/ https://www.ncbi.nlm.nih.gov/pubmed/37404242 http://dx.doi.org/10.1210/jendso/bvad072

Ejemplares similares

Reward Processing During Monetary Incentive Delay Task After Leptin Substitution in Lipodystrophy—an fMRI Case Series
por: Schlögl, Haiko, et al.
Publicado: (2023)

Suggestive Evidence for an Antidepressant Effect of Metreleptin Treatment in Patients with Lipodystrophy
por: Vieira, Diana Branco, et al.
Publicado: (2022)

Increased Growth Differentiation Factor 15 in Patients with Hypoleptinemia-Associated Lipodystrophy
por: Kralisch, Susan, et al.
Publicado: (2020)

Risk factors for diabetic foot ulcers in metreleptin naïve patients with lipodystrophy
por: Saydam, O, et al.
Publicado: (2021)

Metreleptin therapy in LMNA-linked lipodystrophies
por: Vatier, Camille, et al.
Publicado: (2015)

Metreleptin Treatment in Three Patients with Generalized Lipodystrophy
por: Musso, Carla, et al.
Publicado: (2017)

New advances in the treatment of generalized lipodystrophy: role of metreleptin
por: Rodriguez, Alexander J, et al.
Publicado: (2015)

SUN-607 Iron Parameters in Patients with Partial Lipodystrophy and Impact of Metreleptin Therapy
por: Boutros, Sabine, et al.
Publicado: (2020)

Exenatide-Induced Reduction in Energy Intake Is Associated With Increase in Hypothalamic Connectivity
por: Schlögl, Haiko, et al.
Publicado: (2013)

Efficacy and Safety of Metreleptin in Patients with Partial Lipodystrophy: Lessons from an Expanded Access Program
por: Ajluni, Nevin, et al.
Publicado: (2016)

Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to Metreleptin
por: Esfandiari, Nazanene H., et al.
Publicado: (2019)

OR17-02 Changes in Hepatokines and Apolipoproteins Are Associated with Metabolic Response to Metreleptin in Partial Lipodystrophy
por: Akinci, Baris, et al.
Publicado: (2020)

Metreleptin and Metformin Use in an Infant With Congenital Generalized Lipodystrophy Secondary to AGPAT2 Mutation
por: Schweisberger, Cintya, et al.
Publicado: (2021)

FRI056 Effect Of 48 Hour Of Metreleptin In Humans With Lipodystrophy During Controlled Feeding
por: Bukhari, Khulood M, et al.
Publicado: (2023)

SAT676 Severe Recurrent Pancreatitis In A Familial Partial Lipodystrophy Patient On Metreleptin
por: Sargin, Pinar, et al.
Publicado: (2023)

Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report
por: Takeyari, Shinji, et al.
Publicado: (2019)

Metreleptin Supplementation for Improving Lipid and Glycemic Profiles in Acquired Diabetes Lipodystrophy: A Case Report
por: Nagayama, Ayako, et al.
Publicado: (2019)

Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy
por: Nagayama, Ayako, et al.
Publicado: (2021)

SAT089 Natural History Of Generalized Lipodystrophy Following Early Vs. Late Metreleptin Treatment
por: Brush, Maiah, et al.
Publicado: (2023)

The complicated clinical course in a case of atypical lipodystrophy after development of neutralizing antibody to metreleptin: treatment with setmelanotide
por: Akinci, Baris, et al.
Publicado: (2020)

Abdominal fat distribution and its relationship to brain changes: the differential effects of age on cerebellar structure and function: a cross-sectional, exploratory study
por: Raschpichler, Matthias, et al.
Publicado: (2013)

SAT-081 Advanced Lipoprotein Analysis Demonstrates Atherogenic Lipid Profile in Patients with Lipodystrophy That Improves after Metreleptin Treatment
por: Kinzer, Alexandra, et al.
Publicado: (2019)

Metreleptin for the treatment of progressive encephalopathy with/without lipodystrophy (PELD) in a child with progressive myoclonic epilepsy: a case report
por: Pedicelli, Stefania, et al.
Publicado: (2020)

OR33-02 The Treatment of Partial Lipodystrophy in the Setting of Neutralizing Antibody Against Metreleptin with Leptin Receptor Agonist REGN4461
por: Akinci, Baris, et al.
Publicado: (2020)

Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real‐life experience from a national reference network
por: Mosbah, Héléna, et al.
Publicado: (2022)

Obesity-Related Differences between Women and Men in Brain Structure and Goal-Directed Behavior
por: Horstmann, Annette, et al.
Publicado: (2011)

Eigenvector Centrality Mapping for Analyzing Connectivity Patterns in fMRI Data of the Human Brain
por: Lohmann, Gabriele, et al.
Publicado: (2010)

Insulin Administration Acutely Decreases Vaspin Serum Concentrations in Humans
por: Kovacs, Peter, et al.
Publicado: (2013)

Sex and age interact in reading the mind in the eyes
por: Schroeter, Matthias L., et al.
Publicado: (2022)

Leptin Improves Parameters of Brown Adipose Tissue Thermogenesis in Lipodystrophic Mice
por: Hoffmann, Annett, et al.
Publicado: (2021)

Case Report: Metreleptin Treatment in a Patient With a Novel Mutation for Familial Partial Lipodystrophy Type 3, Presenting With Uncontrolled Diabetes and Insulin Resistance
por: Lambadiari, Vaia, et al.
Publicado: (2021)

Progesterone mediates brain functional connectivity changes during the menstrual cycle—a pilot resting state MRI study
por: Arélin, Katrin, et al.
Publicado: (2015)

European lipodystrophy registry: background and structure
por: von Schnurbein, Julia, et al.
Publicado: (2020)

Leptin induces TNFα-dependent inflammation in acquired generalized lipodystrophy and combined Crohn’s disease
por: Ziegler, Jörn F., et al.
Publicado: (2019)

Affect and the Brain's Functional Organization: A Resting-State Connectivity Approach
por: Rohr, Christiane S., et al.
Publicado: (2013)

First Account of Psychological Changes Perceived by a Female with Congenital Leptin Deficiency upon Treatment with Metreleptin
por: Hebebrand, Johannes, et al.
Publicado: (2022)

Correction: Affect and the Brain's Functional Organization: A Resting-State Connectivity Approach
por: Rohr, Christiane S., et al.
Publicado: (2013)

Common Genetic Variation near MC4R Has a Sex-Specific Impact on Human Brain Structure and Eating Behavior
por: Horstmann, Annette, et al.
Publicado: (2013)

Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes
por: Vatier, Camille, et al.
Publicado: (2019)

The Metreleptin Effectiveness and Safety Registry (MEASuRE): concept, design and challenges
por: Haymond, Morey W, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_61jhr015hnhup8k205jb6og460